Up next

Autoplay

Dr. Pautier on Doxorubicin Plus Trabectedin in Soft Tissue Sarcoma

2 Views • 07/18/23
Share
Embed
administrator
administrator
Subscribers
0

Patricia Pautier, MD, discusses the toxicity profile of doxorubicin with trabectedin in the phase 2 LMS-02 trial in patients with metastatic/advanced uterine and soft tissue leiomyosarcoma.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay